Bitterman Kevin's Form 4 filing
Disc Medicine, Inc. (IRON) · filed Jun 20, 2024
- Accession no.
- 0001415889-24-017727
- Filed
- Jun 20, 2024
- Trade date
- Jun 17, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $8.00M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bitterman KevinCIK 0001591747 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | Common Stock | PPurchaseAcquired | +222,223 | $36.00 | +$8,000,028 | 420,549 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The purchase reported herein is matchable, for purposes of Section 16(b) of the Exchange Act, with a series of sales (the "Sales") of shares of Common Stock on January 10, 2024, January 23, 2024 and March 5, 2024 by Opportunity I and Opportunity II, entities in which the Reporting Person has a pecuniary interest. As a result, the Reporting Person is liable for short-swing profits to the extent of his pecuniary interest in the purchase reported herein and the Sales. The Reporting Person has agreed with the Issuer to disgorge the short-swing profits attributable to such pecuniary interest.